In estrogen receptor + breast cancer, Gao et al. (2014) also found high levels of CCNA2, which showed correlation with tamoxifen treatment failure, in which it not only can be used as an independent prognostic factor, but also contributed to the monitoring of tamoxifen efficacy. This evidence concerns the gene CCNA2 and breast carcinoma.